National Claims
Inactive· since Feb 2, 2026
- 53
- days it ran
- 0
- relaunches
Ad copy
EXPOSED: The Dupixent-Lymphoma Link 🔎 4× higher risk. 300+ adverse event reports. FDA investigation launched. The evidence is mounting. If you developed T-cell lymphoma after taking Dupixent, it's time to act.
🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
